A small cohort study presented at the Royal College of Obstetricians & Gynaecologists (RCOG) World Congress 2018 has reported a 5-year diabetic ketoacidosis (DKA) incidence rate of 4.16 percent in pregnant women with type 1 diabetes mellitus (T1DM), with generally good maternal and neonatal outcomes.
Intravenous infusions of ferric carboxymaltose (FCM) may increase haemoglobin (Hb) levels in women with iron deficiency anaemia (IDA), according to a study presented at the RCOG World Congress 2018 held in Singapore.
Mother-to-child transmission (MTCT) of the hepatitis B virus (HBV) from carrier mothers to their infants may be preventable if antiviral therapy is initiated from the third trimester of pregnancy, according to a study presented at RCOG 2018.
Early treatment is recommended for women with genitourinary symptoms of menopause (GSM) or vulvovaginal atrophy, says an expert who presented at the Royal College of Obstetricians & Gynaecologists World Congress 2018 held in Singapore.
Bleeding disorders, such as Von Willebrand disease (VWD), platelet function disorder (PFD), thrombocytopenia, and clotting factor deficiencies, are more prevalent among adolescent girls with heavy menstrual bleeding (HMB), according to a study presented at RCOG World Congress 2018.
Diagnosis of polycystic ovary syndrome (PCOS) is challenging, and there should be no rush to label an adolescent as having the condition before a thorough evaluation of symptoms, according to a leading endocrinologist who was speaking at the RCOG World Congress 2018 in Singapore.
The noninvasive approach appears to be more favourable than surgery for the management of stress urinary incontinence (SUI), according to an expert who presented at the Royal College of Obstetricians & Gynaecologists World Congress 2018 held in Singapore.
Supplementation with omega-3 fatty acids in combination with rosuvastatin may yield significant reductions in triglycerides and nonhigh-density lipoprotein (HDL) cholesterol as compared with rosuvastatin monotherapy, according to data from the ROMANTIC (rosuvastatin-omacor in residual hypertriglyceridemia) trial.
Early treatment with a triple antiviral combination of lopinavir-ritonavir, ribavirin, and interferon beta-1b significantly shortens the duration of virus shedding and reduces symptoms in patients with mild-to-moderate COVID-19 compared with lopinavir-ritonavir only, according to a recent study.
With recent recalls of losartan-containing products contaminated by potentially carcinogenic nitrosamines, MIMS speaks to the Malaysian National Pharmaceutical Regulatory Agency (NPRA) for more details.